Roberta Ruda

OncoDaily

News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary

Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me

March, 2025

Roberta Ruda

Dec 11, 2024, 08:39 | Insight

Vivek Subbiah: From novel diagnostics to cutting-edge therapies like Leptomeningeal Metastatic Disease

Vivek Subbiah, Chief of Early-Phase Drug Development at the Sarah Cannon Research Institute, shared a…

Dec 10, 2024, 14:09 | Blog

Alireza Mansouri: Our comprehensive review on leptomeningeal disease

Alireza Mansouri, Neurosurgeon at Penn State University, shared on X about recent paper by him as…

Nov 15, 2024, 14:24 | Blog

ESTRO-EANO guideline on target delineation and radiotherapy for grade 2 and 3 diffuse glioma

Elisabetta Bonzano, Radiation Oncologist at IRCCS San Matteo Polyclinic Foundation, shared a post on X:…

Oct 14, 2024, 13:10 | Blog

Miguel Bronchud: Astrocyte-dependent local immunosuppression in brain metastasis

Miguel Bronchud, Co-Founder of Regenerative Medicine Solutions, shared on LinkedIn: "Spanish National Center for Cancer…

All: 4 Posts: 1 - 100

'

Karen Knudsen has been appointed as the CEO of the Parker Institute for Cancer Immunotherapy

'

Highlights from ELCC 2025

'

FDA Approved Pluvicto (177Lu-PSMA-617) for Metastatic Castration-Resistant Prostate Cancer

'

Meet the New AACR Board of Directores for 2025-2028 Term

'

Do Artificial Sweeteners Cause Cancer? Myths and Facts

Special Coverage

Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
ESMO 2024 Congress
September 13-17, 2024
ASCO Annual Meeting
May 30 - June 4, 2024
Yvonne Award 2024
May 31, 2024
OncoThon 2024, Online
Feb. 15, 2024
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023